NCT07136909

Brief Summary

Obstructive sleep apnea (OSA) is characterized by repetitive partial and/or total closure of the upper airway during sleep, inducing oxygen desaturation and sleep disturbance. Its prevalence in the pediatric population is 1-5%. In children, OSA can have negative consequences on the cardiovascular system and on the neurocognitive development. It is essential to diagnose OSA and to treat it efficiently. The OSA-18 questionnaire assesses the symptômes of OSA in children and its repercussions. It is composed of 18 items scored on a Likert scale by caregivers. This system allows a more sensitive scoring than binary answers available in other questionnaires like the Pediatric Sleep Questionnaire. The OSA-18 questionnaire would thus be an interesting tool to use for evaluating treatment efficacy in interventional studies and in clinical practice. This questionnaire is not yet available in French. The main objective of this study is thus to evaluate the validity of a French version compared to the gold standard method to evaluate OSA: polysomnography.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
11mo left

Started Nov 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress36%
Nov 2025Apr 2027

First Submitted

Initial submission to the registry

August 7, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

August 22, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

November 1, 2025

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2027

Last Updated

August 22, 2025

Status Verified

August 1, 2025

Enrollment Period

1.4 years

First QC Date

August 7, 2025

Last Update Submit

August 14, 2025

Conditions

Keywords

Obstructive sleep apneasleep disordered breathingquestionnaire

Outcome Measures

Primary Outcomes (1)

  • Scores on the French version of the OSA-18 questionnaire (total score)

    The OSA-18 questionnaire will be filled-in by caregivers.

    Day 2

Study Arms (1)

Children referred to the sleep clinic for polysomnography.

Children aged 4 to 17 years referred hospitalized in the sleep unit of the Hospices Civils de Lyon (France) for polysomnography, for a duration of 24 to 48h.

Other: Completion of the OSA-18 questionnaire by parents, during hospitalization planned as part of routine care.

Interventions

Completion of the OSA-18 questionnaire by parents, during hospitalization planned as part of routine care.

Children referred to the sleep clinic for polysomnography.

Eligibility Criteria

Age4 Years - 17 Years
Sexall
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Children aged 4 to 17 years referred hospitalized in the sleep unit of the Hospices Civils de Lyon (France) for polysomnography, for a duration of 24 to 48h.

You may qualify if:

  • Children hospitalized in the Clinical Epileptology, Sleep Disorders, and Child Functional Neurology Department for polysomnography to screen for OSA,
  • Aged 4 to 17 years inclusive.

You may not qualify if:

  • Parents and/or children object to participation in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Femme-Mère-Enfant

Bron, Rhône, 69500, France

Location

MeSH Terms

Conditions

Sleep Apnea, ObstructiveSleep Apnea Syndromes

Condition Hierarchy (Ancestors)

ApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 7, 2025

First Posted

August 22, 2025

Study Start

November 1, 2025

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

April 1, 2027

Last Updated

August 22, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations